Search
Filter Results
Displaying 471–480 of 578 for “Retinitis pigmentosa”
-
Oct 19, 2020
Foundation NewsThe free November 11 webinar for eye care professionals will convene industry experts to discuss the latest in low vision resources and rehabilitation as well as gaps in low vision care.
-
Oct 8, 2020
“Together, We’re Winning” the Fight Against Blinding Diseases
Foundation NewsFoundation Fighting Blindness Launches New Campaign
-
Sep 24, 2020
Foundation NewsThe event will review best practices for care and management of patients with inherited retinal diseases such as retinitis pigmentosa, Usher syndrome, and Stargardt disease.
-
Virtual VISIONS 2020 Recorded Sessions
Recorded presentations from Virtual Visions 2020.
-
Jun 16, 2020
Foundation Fighting Blindness to Host Virtual VISIONS 2020 Conference
Foundation NewsThe national conference will be held virtually on June 25-27, providing the latest in science and research, practical adapting and thriving, and an opportunity to connect with others who are visually impaired.
-
Oct 18, 2018
FFB Congratulates RPE65 Gene Therapy Researchers for Champalimaud Award
Foundation NewsMore than two decades ago, the Foundation Fighting Blindness (FFB) began funding RPE65 gene therapy research that led in late 2017 to LUXTURNA™, the first FDA-approved gene therapy for the eye or an inherited condition. Ultimately, the Foundation provided more than $10 million in funding for the groundbreaking effort.
-
Jun 8, 2018
Foundation NewsThe Foundation Fighting Blindness (the Foundation) and CheckedUp have formed a collaborative partnership to deliver patient-friendly diagnostic and disease-management information to people with retinal diseases such as age-related macular degeneration, retinitis pigmentosa, and Stargardt disease during their visits to eye doctors.
-
Jan 9, 2018
A Retinal Research Nonprofit Paves the Way for Commercializing Gene Therapies
In the PressAN EMERGING, vision-restoring gene therapy for a devastating retinal disease is poised for Food and Drug Administration (FDA) approval. If it gets the regulatory nod, it will be the first gene therapy to receive FDA approval for the eye or an inherited condition.
-
- Oct 25, 2026
- 9:00 a.m. - 12:00 p.m. (PDT)
- 3000 N Mission Bay Dr, San Diego, CA 92109
VisionWalkJoin us the 19th Annual San Diego VisionWalk!